Uptake of drugs into the intestinal lymphatics after oral administration

https://doi.org/10.1016/S0169-409X(96)00492-9Get rights and content

Abstract

The intestinal lymphatics are a specialised absorption pathway through which dietary lipids, fat soluble vitamins, lipophilic xenobiotics and lipophilic drugs can gain access to the systemic circulation. Compounds absorbed by the intestinal lymphatics drain via the thoracic lymph and enter the systemic circulation at the junction of the left internal jugular vein and the left subclavian vein, thereby avoiding potential first pass metabolism. Consequently, drug transport via the intestinal lymphatics may confer delivery advantages in terms of increased bioavailability (via a reduction in presystemic metabolism) and the possibility of directing delivery to the lymphatic system. The digestion and absorption of lipids is central to the lymphatic transport of lipophilic drugs, and the relevant aspects of these processes are described in the first section of this review. Secondly, methods for predicting and assessing lymphatic drug transport are briefly reviewed, and lastly, common approaches for promoting lymphatic transport are addressed. In this review, the promotion of intestinal lymphatic drug transport is addressed from two standpoints, namely, prodrug formation and formulation optimisation. The physico-chemical and metabolic features of prodrugs designed for enhanced lymphatic transport are discussed, and the advantages and disadvantages of various promoiety strategies are briefly described. Common formulation approaches designed to enhance lymphatic drug delivery are reviewed, with discussion of some recent examples. Finally, the requirement for exogenous lipid to facilitate lymphatic drug transport, and the possibility of directing ‘moderately’ lipophilic compounds through the lymph via formulation approaches, are addressed.

References (98)

  • W.N. Charman et al.

    Estimating the maximal potential for intestinal lymphatic transport of lipophilic drug molecules

    Int. J. Pharm.

    (1986)
  • W.N. Charman et al.

    Lipophilic prodrugs designed for intestinal lymphatic transport

    Adv. Drug Deliv. Rev.

    (1996)
  • T. Noguchi et al.

    Effect of drug lipophilicity and lipid vehicles on the lymphatic absorption of various testosterone esters

    Int. J. Pharm.

    (1985)
  • A. Sakai et al.

    Deacylation-reacylation cycle: a possible absorption mechanism for the novel lymphotropic antitumor agent dipalmitoyl-phosphatidylfluorouridine in rats

    J. Pharm. Sci.

    (1993)
  • J.R. Deverre et al.

    Synthesis and aqueous organization of 1,3-dipalmitoyl-2-(4-aminobutyryl)glycerol.HCl: a diglyceride prodrug

    Chem. Phys. Lipids

    (1991)
  • S. Muranishi

    Drug targeting towards the lymphatics

    Adv. Drug. Res.

    (1991)
  • E. Fernandez et al.

    Effects of tetrahydrolipistatin, a lipase inhibitor on absorption of fat from the rat intestine

    Biochim. Biophys. Acta

    (1989)
  • T. Noguchi et al.

    The effect of drug lipophilicity and lipid vehicles on the lymphatic absorption of various testosterone esters

    Int. J. Pharm.

    (1985)
  • H-X. Liu et al.

    Mechanism of promotion of lymphatic drug absorption by milk fat globule membrane

    Int. J. Pharm.

    (1995)
  • D.J. Hauss et al.

    Targeted lymphatic transport and modified systemic distribution of CI-976, a lipophilic lipid-regulator drug, via a formulation approach

    Int. J. Pharm.

    (1994)
  • C.J.H. Porter et al.

    Lymphatic transport of halofantrine in the conscious rat when administered as either the free base or the hydrochloride salt: effect of lipid class and lipid vehicle dispersion

    J. Pharm. Sci.

    (1996)
  • D.G. White et al.

    An experimental animal model for studying the effects of a novel lymphatic drug delivery system for propranolol

    Int. J. Pharm.

    (1991)
  • S.G. Barnwell et al.

    Improved oral bioavailability of propranolol in healthy human volunteers using a liver bypass drug delivery system containing oleic acid

    Int. J. Pharm.

    (1992)
  • P.G. Green et al.

    Facilitated transfer of cationic drugs across a lipoidal membrane

    Int. J. Pharm.

    (1987)
  • C.R. Pullinger et al.

    The apolipoprotein B gene is constitutively expressed in HepG2 cells: regulation of secretion by oleic acid, albumin and insulin and measurement of the mRNA half life

    J. Lipid Res.

    (1989)
  • R. Homan et al.

    Differential effects of eicosapentaenoic acid and oleic acid on lipid synthesis and secretion by HepG2 cells

    J. Lipid. Res.

    (1991)
  • N. Dashti et al.

    Increased production of apoprotein B and its lipoprotein by oleic acid in Caco2 cells

    J. Lipid Res.

    (1990)
  • J.B. Moberly et al.

    Oleic acid stimulation of apolipoprotein B secretion from HepG2 cells and Caco2 cells occurs post-transcriptionally

    Biochim. Biophys. Acta

    (1990)
  • G. Tucker

    Drug delivery: lymphing along?

    The Lancet

    (1993)
  • Y-F. Shiau

    Mechanism of intestinal fat absorption

    Am. J. Physiol.

    (1981)
  • C.L. Bisgaier et al.

    Intestinal synthesis, secretion and transport of lipoproteins

    Annu. Rev. Physiol.

    (1983)
  • A.B.R. Thomson et al.

    Intestinal aspects of lipid absorption: in review

    Can. J. Physiol. Pharmacol.

    (1989)
  • P. Tso

    Intestinal lipid absorption

  • M.C. Carey et al.

    Lipid digestion and absorption

    Annu. Rev. Physiol.

    (1983)
  • A.F. Hofmann et al.

    Physico-chemical state of lipids in intestinal content during their digestion and absorption

  • A.F. Hofmann et al.

    The intraluminal phase of fat digestion in man: the lipid content of the micellar and oil phases of intestinal content obtained during fat digestion and absorption

    J. Clin. Invest.

    (1964)
  • J.E. Staggers et al.

    Physical-chemical behaviour of dietary and biliary lipids during intestinal digestion and absorption. 1. Phase behaviour and aggregation states of model lipid systems patterned after aqueous duodenal contents of healthy adult human beings

    Biochemistry

    (1990)
  • O. Hernell et al.

    Physical-chemical behaviour of dietary and biliary lipids during intestinal digestion and absorption. 2. Phase analysis and aggregation states of luminal lipids during duodenal fat digestion in healthy adult human beings

    Biochemistry

    (1990)
  • B. Borgstrom et al.

    Studies of intestinal digestion and absorption in the human

    J Clin. Invest.

    (1957)
  • W.J. Simmonds

    The role of micellar solubilisation in lipid absorption

    Aust. J. Exp. Biol. Med. Sci.

    (1972)
  • H. Westergaard et al.

    The mechanism whereby bile acid micelles increase the rate of fatty acid and cholesterol uptake into the mucosal cell

    J. Clin. Invest.

    (1976)
  • M.L. Lucas et al.

    Direct measurement by pH microelectrode of the pH microclimate in rat proximal jejunum

  • Y-F. Shiau et al.

    Mechanisms maintaining a low pH microclimate in the intestine

    Am. J. Physiol.

    (1985)
  • Y-F. Shiau

    Mechanism of intestinal fatty acid uptake in the rat: the role of an acidic microclimate

    J. Physiol.

    (1990)
  • W. Stremmel et al.

    Identification, isolation and partial characterisation of a fatty acid binding protein from rat jejunal microvillus membranes

    J. Clin. Invest.

    (1985)
  • W. Stremmel

    Uptake of fatty acids by jejunal mucosal cells is mediated by a fatty acid binding membrane protein

    J. Clin. Invest.

    (1988)
  • G.B. McDonald et al.

    Partitioning of polar fatty acids into lymph and portal vein after intestinal absorption in the rat

    Q. J. Exp. Physiol.

    (1987)
  • G.B. McDonald et al.

    Portal venous transport of long-chain fatty acids absorbed from rat intestine

    Am. J. Physiol.

    (1980)
  • M. Bugaut et al.

    Role of intestinal hydrolases, endogenous substrates and chyloportal partition in fat absorption

  • Cited by (0)

    View full text